This new investigator-initiated IIb study looks very interesting:

http://finance.yahoo.com/news/Nabi-Bioph...

This could be very promising, as the ability of NicVax to initiate abstinence may be limited, given the long duration of vaccinations required, etc. But, if Chantix, the best med to date, is used to initiate abstinence, then the vaccine can take over after a few months to prevent relapse. If this works, this could become a standard one-two punch in formal treatment. Best news I've seen in at least a year with Nabi.